Biodexa Pharmaceuticals plc ADS/$BDRX
13:30
14:25
15:15
16:10
17:00
1D1W1MYTD1Y5YMAX
About Biodexa Pharmaceuticals plc ADS
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.
Ticker
$BDRX
Sector
Primary listing
Industry
Biotechnology
Headquarters
Employees
13
ISIN
US59564R8079
Website
BDRX Metrics
BasicAdvanced
$2.5M
-
-$15.82
1.20
-
Price and volume
Market cap
$2.5M
Beta
1.2
52-week high
$4.44
52-week low
$0.78
Average daily volume
4.4M
Financial strength
Current ratio
1.75
Quick ratio
1.75
Long term debt to equity
1.418
Total debt to equity
8.736
Interest coverage (TTM)
-55.75%
Profitability
EBITDA (TTM)
-12.423
Effective tax rate (TTM)
4.18%
Management effectiveness
Return on assets (TTM)
-45.41%
Return on equity (TTM)
-88.14%
Valuation
Price to book
0.07
Price to tangible book (TTM)
0.21
Price to free cash flow (TTM)
-0.024
Free cash flow yield (TTM)
-4,192.87%
Free cash flow per share (TTM)
-3,600.04%
Growth
Earnings per share change (TTM)
-94.84%
BDRX News
AllArticlesVideos
Results of Annual General Meeting
GlobeNewsWire·7 days ago
Biodexa Announces Activation of First Clinical Study Site for Phase 3 Serenta Trial in Familial Adenomatous Polyposis (FAP)
GlobeNewsWire·1 week ago
Biodexa Unveils "Serenta" as the Name of its Upcoming Phase 3 Study In Familial Adenomatous Polyposis (FAP)
GlobeNewsWire·2 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Biodexa Pharmaceuticals plc ADS stock?
Biodexa Pharmaceuticals plc ADS (BDRX) has a market cap of $2.5M as of July 04, 2025.
What is the P/E ratio for Biodexa Pharmaceuticals plc ADS stock?
The price to earnings (P/E) ratio for Biodexa Pharmaceuticals plc ADS (BDRX) stock is 0 as of July 04, 2025.
Does Biodexa Pharmaceuticals plc ADS stock pay dividends?
No, Biodexa Pharmaceuticals plc ADS (BDRX) stock does not pay dividends to its shareholders as of July 04, 2025.
When is the next Biodexa Pharmaceuticals plc ADS dividend payment date?
Biodexa Pharmaceuticals plc ADS (BDRX) stock does not pay dividends to its shareholders.
What is the beta indicator for Biodexa Pharmaceuticals plc ADS?
Biodexa Pharmaceuticals plc ADS (BDRX) has a beta rating of 1.2. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.